Synthetic oligosaccharides and glycoconjugates are increasingly used as probes for biological research and as lead compounds for drug and vaccine discovery. These endeavors are, however, complicated by a lack of general methods for the routine preparation of this important class of compounds. Recent development such as one-pot multi-step protecting group manipulations, the use of unified monosaccharide building blocks, the introduction of stereoselective glycosylation protocols, and convergent strategies for oligosaccharide assembly, are beginning to address these problems. Furthermore, oligosaccharide synthesis can be facilitated by chemo-enzymatic methods, which employ a range of glycosyl transferases to modify a synthetic oligosaccharide precursor. Glycosynthases, which are mutant glycosidases, that can readily form glycosidic linkages are addressing a lack of a wide range glycosyltransferases. The power of carbohydrate chemistry is highlighted by an ability to synthesize glycoproteins.There is a growing appreciation that posttranslational modifications, such as glycosylation, dramatically increase protein complexity and function. [1][2][3][4][5][6] For example, almost all cell surface and secreted proteins are modified by covalently-linked carbohydrate moieties and the glycan structures on these glycoproteins have been implicated as essential mediators in processes such as protein folding, cell signaling, fertilization, embryogenesis, neuronal development, hormone activity, and the proliferation of cells and their organization into specific tissues. In addition, overwhelming data supports the relevance of glycans in pathogen recognition, inflammation, innate immune responses, and the development of autoimmune diseases and cancer. [7][8][9][10] The importance of protein glycosylation is also underscored by the developmental abnormalities observed in a growing number of human disorders known as Congenital Disorders of Glycosylation caused by defects in the glycosylation machinery. 11Polysaccharides are major constituents of the microbial cell surfaces and, for example, the bacterial cell wall can contain relatively large amounts of capsular polysaccharides (CPS) or lipopolysaccharides (LPS). 12 These components are important virulence factors by promoting bacterial colonization, blocking phagocytosis, and interfering with leukocyte migration and adhesion. CPS and LPS can be recognized by receptors of the innate immune system leading to the production of cytokines, chemokines, and cellular adhesion molecules.13 -16 With a few exceptions, bacterial polysaccharides can induce an adaptive immune response and, not surprisingly, bacterial saccharides have been employed for the development of vaccines for several pathogens.17 -20